649
Views
30
CrossRef citations to date
0
Altmetric
Infection

Efficacy and safety of 1064-nm Nd:YAG laser in treatment of onychomycosis

, , &
Pages 75-79 | Received 16 Feb 2015, Accepted 20 Mar 2015, Published online: 17 Apr 2015

References

  • Scher RK, Rich P, Pariser D, Elewski Bl. The epidemiology, etiology, and pathophysiology of onychomycosis. Semin Cutan Med Surg. 2013;32:S2–4
  • Elewski BE. Onychomycosis: pathogenesis, diagnosis, and management. Clin Microbiol Rev. 1998;11:415–29
  • Gupta AK, Drummond-Main C, Cooper EA, et al. Systematic review of nondermatophyte mold onychomycosis: diagnosis, clinical types, epidemiology, and treatment. J Am Acad Dermatol. 2012;66:494–502
  • Gupta AK, Simpson FC. New therapeutic options for onychomycosis. Expert Opin Pharmacother. 2012;13:1131–42
  • Lubeck DP, Patrick DL, McNulty P, et al. Quality of life of persons with onychomycosis. Qual Life Res. 1993;2:341–8
  • Drake LA, Scher RK, Smith EB, et al. Effect of onychomycosis on quality of life. J Am Acad Dermatol. 1998;38:702–4
  • Finch JJ, Warshaw EM. Toenail onychomycosis: current and future treatment options. Dermatol Ther. 2007;20:31–46
  • Gupta AK, Uro M, Cooper EA. Onychomycosis therapy: past, present, future. J Drugs Dermatol. 2010;9:1109–13
  • Ortiz AE, Truong S, Serowka K, Kelly KM. A 1,320 nm Nd: YAG laser for improving the appearance of onychomycosis. Dermatol Surg. 2014;40:1356–60
  • Xu Y, Miao X, Zhou B, Luo D. Combined oral terbinafine and long-pulsed 1,064-nm Nd:YAG laser treatment is more effective for onychomycosis than either treatment alone. Dermatol Surg. 2014;40:1201–7
  • Galvan Garcia HR. Onychomycosis: 1064-nm Nd:YAG q-switch laser treatment. J Cosmet Dermatol. 2014;13:232–5
  • Manevitch Z, Lev D, Hochberg M, et al. Direct antifungal effect of femtosecond laser on Trichophyton rubrum onychomycosis. Photochem Photobiol. 2010;86:476–9
  • Landsman AS, Robbins AH. Treatment of mild, moderate, and severe onychomycosis using 870- and 930-nm light exposure: some follow-up observations at 270 days. J Am Podiatr Med Assoc. 2012;102:169–71
  • Marchesini R, Andreola S, Emanuelli H, et al. Temperature rise in biological tissue during Nd:YAG laser irradiation. Lasers Surg Med. 1985;5:75–82
  • Hashimoto T, Blumenthal HJ. Survival and resistance of Trichophyton mentagrophytes arthrospores. Appl Environ Microbiol. 1978;35:274–7
  • Zhang RN, Wang DK, Zhuo FL, et al. Long-pulse Nd:YAG 1064-nm laser treatment for onychomycosis. Chin Med J (Engl). 2012;125:3288–91
  • Moon SH, Hur H, Oh YJ, et al. Treatment of onychomycosis with a 1,064-nm long-pulsed Nd:YAG laser. J Cosmet Laser Ther. 2014;16:165–70
  • Sergeev AY, Gupta AK, Sergeev YV. The Scoring Clinical Index for Onychomycosis (SCIO index). Skin Therapy Lett. 2002;7:6–7
  • Hay RJ. Scytalidium infections. Curr Opin Infect Dis. 2002;15:99–100
  • Ungpakorn R. Mycoses in Thailand: current concerns. Nihon Ishinkin Gakkai Zasshi. 2005;46:81–6
  • Morris-Jones R, Youngchim S, Hextall JM, et al. Scytalidium dimidiatum causing recalcitrant subcutaneous lesions produces melanin. J Clin Microbiol. 2004;42:3789–94
  • Van Duin D, Casadevall A, Nosanchuk JD. Melanization of Cryptococcus neoformans and Histoplasma capsulatum reduces their susceptibilities to amphotericin B and caspofungin. Antimicrob Agents Chemother. 2002;46:3394–400
  • Ikeda R, Sugita T, Jacobson ES, Shinoda T. Effects of melanin upon susceptibility of Cryptococcus to antifungals. Microbiol Immunol. 2003;47:271–7
  • Youn JI, Holcomb JD. Ablation efficiency and relative thermal confinement measurements using wavelength 1,064, 1,320, and 1,444 nm for laser-assisted lipolysis. Lasers Med Sci. 2013;28:519–27
  • Gupta AK, Paquet M. A retrospective chart review of the clinical efficacy of Nd:YAG 1064-nm laser for toenail onycomycosis. J Dermatolog Treat. 2014. [Epub ahead of print]
  • Mishra M, Panda P, Tripathy S, et al. An open randomized comparative study of oral itraconazole pulse and terbinafine pulse in the treatment of onychomycosis. Indian J Dermatol Venereol Leprol. 2005;71:262–6
  • Ingber A. Intermittent low dose itraconazole treatment for onychomycosis - long term follow-up. Med Mycol. 2001;39:471–3
  • Gupta AK, Cooper EA, Paquet M. Recurrences of dermatophyte toenail onychomycosis during long-term follow-up after successful treatments with mono- and combined therapy of terbinafine and itraconazole. J Cutan Med Surg. 2013;17:201–6
  • Scher RK, Tavakkol A, Siqurqeirssor B, et al. Onychomycosis: diagnosis and definition of care. J Am Acad Dermatol. 2007;56:939–44
  • Scher RK, Baran R. Onychomycosis in clinical practice factors contributing to recurrence. Br J Dermatol. 2003;149:5–9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.